Clinical Trials in Los Angeles

Showing 1861-1880 of 8,055 trials

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

NCT04075591

This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subjects at the point of refractive stability. After signing the informed consent, subjects meeting all inclusion and exclusion criteria in both eyes may be scheduled for surgery. The follow-up visit schedule will be the same for each operative eye.

Refractive Error

AMO Development, LLC219 participantsStarted Sep 2019

Los Angeles, California, United States • Chicago, Illinois, United States • Las Vegas, Nevada, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

NCT03112174

This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoclax vs. ibrutinib and placebo in subjects with MCL.

Mantle-Cell Lymphoma

Pharmacyclics LLC.366 participantsStarted Jun 2017

Tucson, Arizona, United States • Duarte, California, United States • Los Angeles, California, United States +117 more locations

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

Find Trials by Condition in Los Angeles

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

Metformin Treatment in Progressive Multiple Sclerosis

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Impact of a Medical-Financial Partnership Intervention on Parent Mental Health, Perinatal Outcomes, and Child Developmental Risk

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

TEE and Dysphagia in Lung Transplantation

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

A Study of RSLV-132 in Females With Sjögren's Disease

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening